XBiotech (XBIT) Selling, General & Administrative (2014 - 2026)
XBiotech (XBIT) posted Selling, General & Administrative of $850,000 for Q2 2026, down 15.0% from $1 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Selling, General & Administrative (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at XBiotech was $7.21 million, up 55.6% year-over-year; for FY2025, it came in at $8.3 million, up 76.0% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of -14.5% (FY2020 to FY2025).
- In prior years, XBiotech's Selling, General & Administrative was $4.71 million in FY2024 (+1.1%), $4.66 million in FY2023 (-26.1%), $6.31 million in FY2022 (-32.8%) and $9.39 million in FY2021 (-48.4%).
- The Q2 2026 figure stands as the lowest quarterly Selling, General & Administrative since Q3 2024.
- On a year-over-year basis, Selling, General & Administrative increased in four of the last seven quarters, with growth averaging 60.0%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2025, with growth of 374.3%; the weakest was Q4 2021, with a decline of 58.4%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | XBiotech | 66.77 Mn | 66.77 Mn | - | 850,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 850,000.00 |
| Dec 31, 2025 | 4.40 Mn |
| Sep 30, 2025 | 967,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 927,000.00 |
| Sep 30, 2024 | 777,000.00 |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Dec 31, 2023 | 783,000.00 |
| Sep 30, 2023 | 973,000.00 |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 915,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 840,000.00 |
| Jun 30, 2022 | 3.02 Mn |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 1.87 Mn |
| Sep 30, 2021 | 1.54 Mn |
| Jun 30, 2021 | 4.52 Mn |
API Access
XBiotech Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();